Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors

Abstract:
ULURU Inc. (Amex: ULU) announced today that Ronald A. Ahrens has been appointed to serve on the
Company's Board of Directors.

ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors

ADDISON, TX | Posted on June 23rd, 2008

Mr. Ahrens has been an advisor to Merck & Company, Inc. since 1995, when
he retired as President of Merck Consumer Healthcare Group Worldwide. He had
previously served as Executive Vice President of Merck Consumer Healthcare
Group International. From 1985 to 1990 Mr. Ahrens was Consumer Group
President, North America of Bristol-Myers Squibb and previously was President
of Bristol Myers Products Division. Prior to 1985, he held senior management
and sales and marketing positions with Richardson Vicks, Bristol-Myers Squibb
and Procter and Gamble.

"I am extremely impressed with ULURU's range of innovative products and
look forward to providing insight and guidance as they commercialize their
numerous product opportunities. The company is now at a point where I believe
my experience can assist the company to enhance share holder value," said Mr.
Ahrens.

Commenting on the appointment, Kerry P. Gray, President and Chief
Executive Officer of ULURU, stated, "We are excited to have Ron join our
Board, as he has vast experience successfully commercializing numerous
products, and has been involved with a wound care company. His extensive
industry experience and contacts will be extremely helpful as we commercialize
products both internally and with strategic partners."

####

About ULURU Inc.
ULURU Inc. is a specialty pharmaceutical company focused on the
development of a portfolio of wound management, plastic surgery and oral care
products to provide patients and consumers improved clinical outcomes through
controlled delivery utilizing its innovative transmucosal delivery system and
Hydrogel Nanoparticle Aggregate technology.

This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as amended,
including but not limited to statements made relating to the value of our
products in the marketplace, our ability to develop and market our
technologies and commercialization of products in the marketplace. These
statements are subject to numerous risks and uncertainties, including but not
limited to the risk factors detailed in the Company's Annual Report on Form
10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for
the quarter ended March 31, 2008 and other reports filed by us with the
Securities and Exchange Commission.

For more information, please click here

Contacts:
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

Nanomedicine

NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014

Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014

RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Announcements

Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Appointments/Promotions/New hires/Resignations/Deaths

First Canada Excellence Research Chair gets $10 million from the federal government for oilsands research at the University of Calgary: Federal government announces prestigious research chair to study improving oil production efficiency October 19th, 2014

VDMA photonics steering committee with new members stronger than ever October 14th, 2014

Agar Scientific appoints Paul Balaş as new Technical Sales Manager October 3rd, 2014

PEN Inc. Chairman Scott Rickert Announces Company Vision, Product Priorities and Management Team: Webcast Highlights the Launch of PEN October 3rd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE